Margherita Oberti

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative Analysis.

Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative Analysis.

Journal: Cancers
Published: August 04, 2024

COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.

COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.

Journal: Hematological oncology
Published: November 27, 2022

Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.

Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.

Journal: Cancers
Published: August 24, 2022

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.

Journal: Hematological oncology
Published: May 16, 2022

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Journal: Journal of hematology & oncology
Published: July 09, 2021

Isavuconazole-Animal Data and Clinical Data.

Isavuconazole-Animal Data and Clinical Data.

Journal: Journal of fungi (Basel, Switzerland)
Published: September 07, 2020

Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.

Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.

Journal: Hematological oncology
Published: August 11, 2020

Safety of local anesthesia and prevalence of hypersensitivity reactions in adult patients with clonal mast cell diseases: A retrospective single-center study.

Safety of local anesthesia and prevalence of hypersensitivity reactions in adult patients with clonal mast cell diseases: A retrospective single-center study.

Journal: The journal of allergy and clinical immunology. In practice
Published: July 17, 2020

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

Journal: The Lancet. Haematology
Published: June 09, 2020

Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.

Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.

Journal: Cancer
Published: May 22, 2020

Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.

Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.

Journal: Hematological oncology
Published: February 18, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026